AstraZeneca to Harness Benefits of Genome-Editing Technology

AstraZeneca has unveiled agreements that should enable the U.K. pharmaceutical company to tap into a promising, nascent gene technology aimed at making drugs more precise.



from WSJ.com: US Business http://ift.tt/1tx00JN

via IFTTT